Genetic products differentially expressed in tumors and the use thereof | Patent Number 10414824

US 10414824 B2
Application Number15650092
Publication NumberUS 20170320963 A1
Pendency2 years, 2 months, 5 days
Filled DateJul 14, 2017
Priority DateNov 21, 2003
Publication DateNov 9, 2017
Expiration DateNov 21, 2023
Inventor/ApplicantsMichael Koslowski
Ozlem Tureci
Ugur Sahin
ExaminesREDDIG, PETER J
Art Unit1642
Technology Center1600
Assignments
Biontech Ag
Current
Ganymed Pharmaceuticals AgAstellas Pharma Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.